![](/img/cover-not-exists.png)
E46Phase III study of regorafenib versus placebo as maintenance therapy in RAS wild type metastatic colorectal cancer (RAVELLO trial)
Martinelli, E., Troiani, T., Venturini, F., Cervantes Rupierez, A., Douillard, J.Y., Falcone, A., Folprecht, G., Kohne, C., Taieb, J., Tabernero, J., Cardone, C., Sforza, V., Martini, G., Napolitano,Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv340.46
Date:
October, 2015
File:
PDF, 33 KB
english, 2015